XGN Earnings & Financial Statements
Exagen Inc.
$8.19
-$0.27(-3.19%)
58
Overall
40
Value
91
Tech
44
Quality
Market Cap
$204.95M
Volume
271.75K
52W Range
$2.59 - $12.23
Target Price
$10.14
XGN earnings and financial statements: Exagen Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
XGN Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $66.58M | $55.64M | $52.55M | $45.56M | $48.30M |
| Cost of revenue | $27.78M | $22.53M | $23.09M | $24.21M | $20.59M |
| Operating income | -$14.07M | -$13.64M | -$22.84M | -$46.05M | -$24.07M |
| EBITDA | -$13.09M | -$10.99M | -$19.00M | -$43.66M | -$23.10M |
| Net income | -$19.95M | -$15.12M | -$23.69M | -$47.39M | -$26.85M |
| EPS (diluted) | $-0.93 | $-0.83 | $-1.34 | $-2.77 | $-1.68 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $58.02M | $44.69M | $56.94M | $86.22M | $123.44M |
| Total liabilities | $40.57M | $35.15M | $34.25M | $43.76M | $38.51M |
| Shareholders’ equity | $17.45M | $9.54M | $22.69M | $42.46M | $84.94M |
| Cash and equivalents | $32.22M | $22.04M | $36.49M | $62.39M | $99.44M |
| Long-term debt | $24.66M | $21.64M | $21.99M | $33.27M | $27.48M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$13.63M | -$13.28M | -$14.46M | -$32.14M | -$20.27M |
| Capital expenditure | -$626.0K | -$515.0K | -$828.0K | -$4.32M | -$2.37M |
| Free cash flow | -$14.27M | -$13.79M | -$15.29M | -$36.46M | -$22.64M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | XGN | $8.19 | -3.2% | 271.75K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |